Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Cell Reports
|
June 21, 2016
In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer
Alessandro Carugo, Giannicola Genovese, Sahil Seth, et al.
Science Advances
|
March 13, 2024
Clonal dominance defines metastatic dissemination in pancreatic cancer
I-Lin Ho, Chieh-Yuan Li, Fuchenchu Wang, et al.
Cell Reports
|
January 10, 2019
Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation
Yuting Sun, Madhavi Bandi, Timothy Lofton, et al.
Nature
|
February 9, 2017
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer
Giannicola Genovese, Alessandro Carugo, James Tepper, et al.
Cancer Research
|
April 6, 2026
DPY30 is an epigenetic decoupler linking replication stress to immunoediting in pancreatic cancer
Francesca Citron, Luca Cecchetto, Elisabetta Granato, et al.
Nature Communications
|
July 31, 2021
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma
Virginia Giuliani, Meredith A Miller, Chiu-Yi Liu, et al.
Cancer Cell
|
May 4, 2020
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma
Pavlos Msaouel, Gabriel G Malouf, Xiaoping Su, et al.
Nature Cancer
|
June 26, 2023
Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer
Luigi Perelli, Federica Carbone, Li Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
November 1, 2024
WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancer
Francesca Citron, I-Lin Ho, Chiara Balestrieri, et al.
Journal of Medicinal Chemistry
|
October 29, 2020
Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties
Michael J Soth, Kang Le, Maria Emilia Di Francesco, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Cell Reports
|
June 21, 2016
In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer
Alessandro Carugo, Giannicola Genovese, Sahil Seth, et al.
Science Advances
|
March 13, 2024
Clonal dominance defines metastatic dissemination in pancreatic cancer
I-Lin Ho, Chieh-Yuan Li, Fuchenchu Wang, et al.
Cell Reports
|
January 10, 2019
Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation
Yuting Sun, Madhavi Bandi, Timothy Lofton, et al.
Nature
|
February 9, 2017
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer
Giannicola Genovese, Alessandro Carugo, James Tepper, et al.
Cancer Research
|
April 6, 2026
DPY30 is an epigenetic decoupler linking replication stress to immunoediting in pancreatic cancer
Francesca Citron, Luca Cecchetto, Elisabetta Granato, et al.
Nature Communications
|
July 31, 2021
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma
Virginia Giuliani, Meredith A Miller, Chiu-Yi Liu, et al.
Cancer Cell
|
May 4, 2020
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma
Pavlos Msaouel, Gabriel G Malouf, Xiaoping Su, et al.
Nature Cancer
|
June 26, 2023
Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer
Luigi Perelli, Federica Carbone, Li Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
November 1, 2024
WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancer
Francesca Citron, I-Lin Ho, Chiara Balestrieri, et al.
Journal of Medicinal Chemistry
|
October 29, 2020
Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties
Michael J Soth, Kang Le, Maria Emilia Di Francesco, et al.
Page
of 3